Botox Drug Interactions
Currently displaying 94 drugs known to have a moderate interaction with Botox (onabotulinumtoxinA).
- 25 major drug interactions
- 94 moderate drug interactions
Moderate interactions with Botox (onabotulinumtoxinA)
Note: Showing generic names only.
A
B
C
- carbinoxamine
- carisoprodol
- chlorcyclizine
- chlorphenesin
- chlorpheniramine
- chlorpromazine
- chlorzoxazone
- clemastine
- clidinium
- clomipramine
- clozapine
- cyclizine
- cyclobenzaprine
- cyproheptadine
D
- dantrolene
- darifenacin
- daxibotulinumtoxinA
- desipramine
- dexbrompheniramine
- dexchlorpheniramine
- dicyclomine
- dimenhydrinate
- diphenhydramine
- disopyramide
- doxepin
- doxepin topical
- doxylamine
F
G
H
I
L
M
- maprotiline
- meclizine
- mepenzolate
- mesoridazine
- metaxalone
- methdilazine
- methocarbamol
- methotrimeprazine
- methscopolamine
- molindone
N
O
P
- perphenazine
- phenindamine
- pimozide
- prabotulinumtoxinA
- prochlorperazine
- procyclidine
- promazine
- promethazine
- propantheline
- propiomazine
- protriptyline
- pyrilamine
Q
R
S
T
- thiethylperazine
- thioridazine
- thiothixene
- tiotropium
- tizanidine
- tolterodine
- trifluoperazine
- triflupromazine
- trihexyphenidyl
- trimeprazine
- trimipramine
- tripelennamine
- triprolidine
- trospium
Botox disease interactions
There are 3 disease interactions with Botox (onabotulinumtoxinA) which include:
More about Botox (onabotulinumtoxinA)
- Botox consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (467)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: skeletal muscle relaxants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.